TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7489796

Group type: EXPERIMENTAL
Intervention: Cold dry air during exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Room air during exercise
Number of subjects: 100
Study: 2107608

Group type: EXPERIMENTAL
Intervention: Standard PN solution
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 10% dextrose water (D10W)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (meal)
Number of subjects: 7
Study: 109382

Group type: EXPERIMENTAL
Intervention: Butalamine hydrochloride tablets (80 mg each), daily dose of 3 x 2 tablets
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Butalamine hydrochloride tablets (80 mg each), daily dose of 3 x 1 tablet
Number of subjects: 113
Study: 29905879

Group type: EXPERIMENTAL
Intervention: Group-based psychosocial interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 27273839

Group type: EXPERIMENTAL
Intervention: Pictorial warnings on cigarette packs
Number of subjects: 2149

Group type: COMPARATOR
Intervention: Text-only warnings on cigarette packs
Number of subjects: 2149
Study: 26181221

Group type: EXPERIMENTAL
Intervention: Protocolized sedation
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Protocolized sedation plus daily interruption
Number of subjects: 289

Group type: COMPARATOR
Intervention: No ICU recall
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Delusional memories
Number of subjects: 289
Study: 21951313

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab injection (IVBI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab injection (IVRI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both IVBI and IVRI
Number of subjects: 50
Study: 21903553

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maintenance therapy without chlorhexidine
Number of subjects: 20
Study: 17486573

Group type: EXPERIMENTAL
Intervention: Alcohol condition (intoxication)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: High salience cue
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low salience cue
Number of subjects: 74
Study: 16639071

Group type: EXPERIMENTAL
Intervention: Skin incision omission PEG (IOPEG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard PEG (SPEG)
Number of subjects: 50
Study: 14534519

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (2 mg estradiol valerate and 250 microg levonorgestrel)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral contraceptive (30 microg ethinyl estradiol and 150 microg desogestrel)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control phase (150 mg bupropion without pretreatment)
Number of subjects: 12
Study: 10591840

Group type: EXPERIMENTAL
Intervention: Recent physical activity, Lean mass, African-American race
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Dietary protein, calcium, recent physical activity
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Lean body mass, premenopausal status
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Lean body mass, physical activity, African-American race, body mass index
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 393
Study: 7784119

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) urinary tract prophylaxis
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (discontinuing antibiotic prophylaxis)
Number of subjects: 43
Study: 2352049

Group type: EXPERIMENTAL
Intervention: Middle Ear Implant (MEI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hearing Aid (HA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Middle Ear Implant (MEI) and Hearing Aid (HA)
Number of subjects: 10
Study: 345380

Group type: EXPERIMENTAL
Intervention: Carbuterol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 20
Study: 30021451

Group type: EXPERIMENTAL
Intervention: Process incentives for attending weekly Diabetes Prevention Program sessions
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: Outcome incentives for achieving weekly weight loss goals
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: Combined process and outcome incentives
Number of subjects: 703

Group type: COMPARATOR
Intervention: Control (no incentives)
Number of subjects: 703
Study: 28542112

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation combined with conventional physical therapy (40 min + 20 min for 3 weeks, then 60 min conventional therapy for 3 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional physical therapy (60 min for 6 weeks)
Number of subjects: 28
Study: 27037872

Group type: EXPERIMENTAL
Intervention: Customized home-based exercise (HE)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Group-based exercise (GE)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (CG) receiving usual community care
Number of subjects: 210
Study: 23494779

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (MMA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 21846286

Group type: EXPERIMENTAL
Intervention: Worksite health promotion intervention
Number of subjects: 0
Study: 19594199

Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17893252

Group type: EXPERIMENTAL
Intervention: Somatostatin-14 (SS-14) 2.0 microg/kg per h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cortistatin-17 (CST-17) 2.0 microg/kg per h
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 9
Study: 15717651

Group type: EXPERIMENTAL
Intervention: AVP test (0.3 UI iv bolus)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: APZ/AVP test (0.5 mg at midnight and 0.5 mg 90 min before the test)
Number of subjects: 23

Group type: COMPARATOR
Intervention: APZ (0.5 mg at midnight and 0.5 mg 90 min before the test)
Number of subjects: 23
Study: 12097783

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg/day
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Fluoxetine 90 mg twice a week
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study: 9817625

Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg/day)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Citalopram (20-60 mg/day)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Sertraline or Citalopram
Number of subjects: 308
Study: 7703061

Group type: EXPERIMENTAL
Intervention: Endovascular occlusion of side branches (EAI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional open technique (CI)
Number of subjects: 64
Study: 31906903

Group type: EXPERIMENTAL
Intervention: Mindfulness-integrated cognitive behavior therapy (MiCBT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual treatment (wait-list control)
Number of subjects: 120
Study: 29037845

Group type: EXPERIMENTAL
Intervention: Model osteoarthritis consultation
Number of subjects: 525

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 525
Study: 28029669

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anaesthesia (group 1)
Number of subjects: 60
Study: 25582305

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 40
Study: 23043450

Group type: EXPERIMENTAL
Intervention: Arrow CorAide left ventricular assist system (LVAS)
Number of subjects: 21
Study: 21966064

Group type: EXPERIMENTAL
Intervention: ramelteon (8 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: zopiclone (7.5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 19786427

Group type: EXPERIMENTAL
Intervention: Maternal salivary cotinine levels (SCLs) > or =20 ng/mL
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Maternal salivary cotinine levels (SCLs) > or =50 ng/mL
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Maternal salivary cotinine levels (SCLs) > or =100 ng/mL
Number of subjects: 714
Study: 16679271

Group type: EXPERIMENTAL
Intervention: Dual-head power injector using 0.6 mL/kg contrast flushed by 30 mL of saline solution (group D)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Single-head power injector using 1.0 mL/kg contrast only (group S)
Number of subjects: 151
Study: 15385017

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sevoflurane and Halothane (combined)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 120
Study: 11253523

Group type: COMPARATOR
Intervention: Jet lavage
Number of subjects: 57
Study: 9292481

Group type: EXPERIMENTAL
Intervention: DeltaR magnitudes presented at the onset of an inspiration or by interrupting an inspiration (n = 9)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Three DeltaR magnitudes (n = 6)
Number of subjects: 15
Study: 8512761

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg once daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Enalapril (5-20 mg once daily)
Number of subjects: 31
Study: 3566999

Group type: EXPERIMENTAL
Intervention: Radial artery cannulation (group I)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dorsalis pedis artery cannulation (group II)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 46
Study: 29088414

Group type: EXPERIMENTAL
Intervention: Peer education group (PEG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Care provider group (CPG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 120
Study: 27854354

Group type: EXPERIMENTAL
Intervention: WHO STOPS intervention involving community engagement and action plans
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no specific interventions)
Number of subjects: 10
Study: 25433826

Group type: EXPERIMENTAL
Intervention: Couple relationship education integrated in antenatal education
Number of subjects: 0
Study: 21917562

Group type: EXPERIMENTAL
Intervention: Distant healing
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study: 20435569

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Initial AUC/MIC > 119
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: AUC/MIC < 176
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa
Number of subjects: 74
Study: 18515735

Group type: EXPERIMENTAL
Intervention: Upfront zoledronic acid (4 mg intravenously every 6 months)
Number of subjects: 1667

Group type: COMPARATOR
Intervention: Delayed zoledronic acid
Number of subjects: 1667
Study: 15811162

Group type: EXPERIMENTAL
Intervention: Ome‐Mg 20 (20.6 mg omeprazole magnesium)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ome‐Mg 10 (10.3 mg omeprazole magnesium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12026923

Group type: EXPERIMENTAL
Intervention: Mandibular teeth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maxillary teeth
Number of subjects: 0
Study: 10203078

Group type: EXPERIMENTAL
Intervention: Nutritional support supplemented with key nutrients (Impact, Immun‐Aid)
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Standard nutritional support
Number of subjects: 1009
Study: 8787952

Group type: EXPERIMENTAL
Intervention: rhGH (2 IU) + Hex (2 micrograms/kg iv)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline + Hex (2 micrograms/kg iv)
Number of subjects: 5
Study: 1668125

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/day for three days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg acute dose
Number of subjects: 30
Study: 6958483

Group type: EXPERIMENTAL
Intervention: Budesonide administered three hours before challenge
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Budesonide administered twice daily for one week before challenge
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Budesonide (one week's treatment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo administered three hours before challenge
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (one week's treatment)
Number of subjects: 12
Study: 31030867

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Active psychological treatment (control)
Number of subjects: 82
Study: 29237686

Group type: EXPERIMENTAL
Intervention: Family Heart Talk intervention
Number of subjects: 1300
Study: 25670916

Group type: COMPARATOR
Intervention: Passive chair transfer
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitting on the edge of the bed
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of sitting on the edge of the bed vs passive chair transfer
Number of subjects: 10
Study: 24323549

Group type: EXPERIMENTAL
Intervention: CSL30 (30 ml kg(-1) crystalloid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CSL10 (10 ml kg(-1) crystalloid)
Number of subjects: 100
Study: 21695405

Group type: EXPERIMENTAL
Intervention: Approach Imagery
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Approach Imagery combined with Process Imagery
Number of subjects: 182
Study: 19686479

Group type: EXPERIMENTAL
Intervention: Total Intravenous Anaesthesia (TIVA)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 414
Study: 17538803

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 281

Group type: COMPARATOR
Intervention: Pimecrolimus cream 1%
Number of subjects: 281
Study: 14762857

Group type: EXPERIMENTAL
Intervention: Interferon and ribavirin combination therapy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Interferon monotherapy
Number of subjects: 119
Study: 11328902

Group type: EXPERIMENTAL
Intervention: Oral iron (ferrous sulphate 200 mg tds)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intravenous iron (300 mg iron sucrose monthly)
Number of subjects: 45
Study: 9308269

Group type: EXPERIMENTAL
Intervention: Analgesia suggestion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Word memory task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pursuit-rotor task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-control (minds wandering)
Number of subjects: 0
Study: 8185690

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (CSA) - initial dosage 2.5 mg/kg/day, maintenance dosage 3.6 mg/kg/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Chloroquine (CQ) - initial dosage 300 mg/day, maintenance dosage 100 mg/day
Number of subjects: 44
Study: 3358238

Group type: EXPERIMENTAL
Intervention: Combination of intramuscular streptomycin plus oral tetracycline over 14 days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 14-day course of oral co-trimoxazole (trimethoprim-sulfamethoxazole)
Number of subjects: 37
Study: 31135265

Group type: EXPERIMENTAL
Intervention: Standard five-port technique with a fan-type liver retractor (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Four-port technique with liver retracted using a polypropylene suture (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 28904247

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 361

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 361
Study: 25886031

Group type: EXPERIMENTAL
Intervention: N95 filtering facepiece respirators with filter resistive loads of 94.1 Pa - 119.6 Pa pressure
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention (without N95 respirators)
Number of subjects: 32
Study: 24203808

Group type: EXPERIMENTAL
Intervention: Bilateral AcrySof ReSTOR +3.0 D toric IOLs (Models SND1T3, SND1T4, or SND1T5)
Number of subjects: 49
Study: 21365126

Group type: EXPERIMENTAL
Intervention: 50 mg ITF2357 (givinostat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg ITF2357 (givinostat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg ITF2357 (givinostat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 400 mg ITF2357 (givinostat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600 mg ITF2357 (givinostat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily dosing of 50 or 100 mg ITF2357 (givinostat)
Number of subjects: 0
Study: 19082653

Group type: EXPERIMENTAL
Intervention: Rikkunshito 7.5 g/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (without rikkunshito)
Number of subjects: 11
Study: 17250926

Group type: EXPERIMENTAL
Intervention: Traditional meal context (meal condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-meal context (tasting session)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identical meal context (preload)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-meal context (preload)
Number of subjects: 0
Study: 15114302

Group type: EXPERIMENTAL
Intervention: Endoscopic papillary balloon dilation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 12100048

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 1302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Loratadine
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Montelukast and Loratadine
Number of subjects: 1302
Study: 9682339

Group type: EXPERIMENTAL
Intervention: Two doses of 0.1 ml of inactivated poliovirus vaccine (IPV) intradermally 8 weeks apart (group A)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Three doses of inactivated poliovirus vaccine (IPV) intradermally 4 weeks apart (group B)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Infants without pre-existing maternal antibody in both groups
Number of subjects: 78
Study: 7940114

Group type: EXPERIMENTAL
Intervention: ondansetron 32 mg iv 1 hour prior to treatment +/‐ corticosteroids
Number of subjects: 10

Group type: COMPARATOR
Intervention: prochlorperazine +/‐ corticosteroids
Number of subjects: 10
Study: 2510140

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 1000 mg aspirin as lysine salt
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral administration of 1000 mg aspirin as lysine salt
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 1000 mg aspirin as lysine salt
Number of subjects: 18
Study: 1096292

Group type: EXPERIMENTAL
Intervention: Human exogenous interferon (1 million units, intramuscularly, for 5-8 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Culture medium (control)
Number of subjects: 37
Study: 31464460

Group type: EXPERIMENTAL
Intervention: Micro-breaks of varying durations and activities
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Micro-breaks
Number of subjects: 232
Study: 30139553

Group type: EXPERIMENTAL
Intervention: NAVIGATE program
Number of subjects: 404

Group type: COMPARATOR
Intervention: Usual Community Care
Number of subjects: 404
Study: 28068520

Group type: EXPERIMENTAL
Intervention: 12-week quadriceps strengthening program
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 97
Study: 25963237

Group type: EXPERIMENTAL
Intervention: Exercise group (EG); 2 supervised group and 2 home exercise sessions/week
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (CG); requested to maintain their physical activity
Number of subjects: 137
Study: 23351405

Group type: EXPERIMENTAL
Intervention: AHCC supplementation (3 g/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 21173385

Group type: EXPERIMENTAL
Intervention: B.A.Bar dialogue training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nonlinguistic training
Number of subjects: 18
Study: 21141018

Group type: COMPARATOR
Intervention: Local anesthesia without sedation (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Local anesthesia with sedation (Group B)
Number of subjects: 100
Study: 17426620

Group type: EXPERIMENTAL
Intervention: Chronic neck pain patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chronic neck pain patients and Control group
Number of subjects: 100
Study: 15108976

Group type: EXPERIMENTAL
Intervention: Variable ventilation (VV)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control mode ventilation (CV)
Number of subjects: 41
Study: 11170993

Group type: EXPERIMENTAL
Intervention: Higher SLPI concentrations (>100 ng/mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lower SLPI concentrations (<100 ng/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vaginal fluid SLPI concentrations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vaginal HIV‐1 concentrations
Number of subjects: 60
Study: 7995992

Group type: EXPERIMENTAL
Intervention: Peru-3 vaccine strain
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Peru-14 vaccine strain
Number of subjects: 15

Group type: COMPARATOR
Intervention: Peru-3 or Peru-5 vaccinees
Number of subjects: 15
Study: 2921255

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard fluid resuscitation (control)
Number of subjects: 22
Study: 170820

Group type: EXPERIMENTAL
Intervention: Oral glucose (50% of calories) during period IV
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intravenous glucose (50% of calories) during period III
Number of subjects: 7

Group type: COMPARATOR
Intervention: Carbohydrate-free diet (70% fat and 30% protein) during period II
Number of subjects: 7
Study: 31122846

Group type: EXPERIMENTAL
Intervention: Anatomic reaming technique
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional reaming technique
Number of subjects: 131